Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization

被引:48
作者
Banke, TG
Greenwood, JR
Christensen, JK
Liljefors, T
Traynelis, SF
Schousboe, A
Pickering, DS
机构
[1] Royal Danish Sch Pharm, Dept Pharmacol, DK-2100 Copenhagen, Denmark
[2] Royal Danish Sch Pharm, Dept Med Chem, DK-2100 Copenhagen, Denmark
[3] Royal Danish Sch Pharm, Dept Med Chem, DK-2100 Copenhagen, Denmark
[4] Royal Danish Sch Pharm, Neurosci PharmaBiotech Res Ctr, DK-2100 Copenhagen, Denmark
[5] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
AMPA receptor; desensitization; binding site; GluR1; GluR2; GluR3; GluR4 agonist subtype-selectivity; mutant receptors;
D O I
10.1523/JNEUROSCI.21-09-03052.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Although GluR1(o) and GluR3(o) are homologous at the amino acid level, GluR3(o) desensitizes approximately threefold faster than GluR1(o). By creating chimeras of GluR1(o) and GluR3(o) and point amino acid exchanges in their S2 regions, two residues were identified to be critical for GluR1(o) desensitization: Y716 and the R/G RNA-edited site, R757. With creation of the double-point mutant (Y716F, R757G) GluR1(o), complete exchange of the desensitization rate of GluR1(o) to that of GluR3(o) was obtained. In addition, both the potency and affinity of the subtype-selective agonist bromohomoibotenic acid were exchanged by the Y716F mutation. A model is proposed of the AMPA receptor binding site whereby a hydrogen-bonding matrix of water molecules plays an important role in determining both ligand affinity and receptor desensitization properties. Residues Y716 in GluR1 and F728 in GluR3 differentially interact with this matrix to affect the binding affinity of some ligands, providing the possibility of developing subtype-selective compounds.
引用
收藏
页码:3052 / 3062
页数:11
相关论文
共 41 条
[1]
Agonist-induced isomerization in a glutamate receptor ligand-binding domain -: A kinetic and mutagenetic analysis [J].
Abele, R ;
Keinänen, K ;
Madden, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21355-21363
[2]
Mechanisms for activation and antagonism of an AMPA-Sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core [J].
Armstrong, N ;
Gouaux, E .
NEURON, 2000, 28 (01) :165-181
[3]
Structure of a glutamate-receptor ligand-binding core in complex with kainate [J].
Armstrong, N ;
Sun, Y ;
Chen, GQ ;
Gouaux, E .
NATURE, 1998, 395 (6705) :913-917
[4]
Banke TG, 1997, J NEUROSCI RES, V49, P176, DOI 10.1002/(SICI)1097-4547(19970715)49:2<176::AID-JNR6>3.0.CO
[5]
2-6
[6]
Glutamate in neurologic diseases [J].
Bittigau, P ;
Ikonomidou, C .
JOURNAL OF CHILD NEUROLOGY, 1997, 12 (08) :471-485
[7]
BROSE N, 1994, J BIOL CHEM, V269, P16780
[8]
EXCITATORY AMINO-ACID RECEPTOR LIGANDS - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 3-ISOXAZOLOL AMINO-ACIDS STRUCTURALLY RELATED TO HOMOIBOTENIC ACID [J].
CHRISTENSEN, IT ;
EBERT, B ;
MADSEN, U ;
NIELSEN, B ;
BREHM, L ;
KROGSGAARDLARSEN, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (19) :3512-3519
[9]
Agonist discrimination between AMPA receptor subtypes [J].
Coquelle, T ;
Christensen, JK ;
Banke, TG ;
Madsen, U ;
Schousboe, A ;
Pickering, DS .
NEUROREPORT, 2000, 11 (12) :2643-2648
[10]
Dingledine R, 1999, PHARMACOL REV, V51, P7